Marie-claude Zaluski-Fournie

Paris BioPark, 11 Rue Watt
Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Substituted α-mercaptoketones, new types of specific neprilysin inhibitors.

Substituted α-mercaptoketones, new types of specific neprilysin inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: April 27, 2017

Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.

Synergistic combinations of the dual enkephalinase inhibitor PL265 given orally with various analgesic compounds acting on different targets, in a murine model of cancer-induced bone pain.

Journal: Scandinavian journal of pain

Published: June 24, 2016

Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.

Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.

Journal: European journal of pharmacology

Published: January 22, 2016

Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route.

Modulation of disulfide dual ENKephalinase inhibitors (DENKIs) activity by a transient N-protection for pain alleviation by oral route.

Journal: European journal of medicinal chemistry

Published: May 22, 2015

Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.

Long-lasting oral analgesic effects of N-protected aminophosphinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain.

Journal: Pharmacology research & perspectives

Published: September 12, 2014

New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.

New orally active dual enkephalinase inhibitors (DENKIs) for central and peripheral pain treatment.

Journal: Journal of medicinal chemistry

Published: June 14, 2014

Comparison of fluorigenic peptide substrates PL50, SNAPTide, and BoTest A/E for BoNT/A detection and quantification: exosite binding confers high-assay sensitivity.

Comparison of fluorigenic peptide substrates PL50, SNAPTide, and BoTest A/E for BoNT/A detection and quantification: exosite binding confers high-assay sensitivity.

Journal: Journal of biomolecular screening

Published: February 22, 2013

A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.

A sensitive fluorigenic substrate for selective in vitro and in vivo assay of leukotriene A4 hydrolase activity.

Journal: Analytical biochemistry

Published: January 02, 2013

Highly sensitive quenched fluorescent substrate of Legionella major secretory protein (msp) based on its structural analysis.

Highly sensitive quenched fluorescent substrate of Legionella major secretory protein (msp) based on its structural analysis.

Journal: The Journal of biological chemistry

Published: April 25, 2012

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Journal: Nature reviews. Drug discovery

Published: March 31, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026